Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 2
March – April 2003
Heart Drug Cover Image for Volume 3, Issue 2
All Issues
ISSN 1422-9528
EISSN 1424-0556

Journal Name Change

Merged with Vol. 6 (2006) into: Cardiology.

Heart Drug 2003, Vol. 3, No. 2

News from the ESC Working Group ‘Cardiovascular Pharmacology and Drug Therapy’

Good News!
Heart Drug (2003) 3 (2): 65–66. https://doi.org/10.1159/000071991
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Clinical Trial

Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy
B.K. Kilhovd; E. Hjerkinn; I. Seljeflot; Å. Reikvam
Heart Drug (2003) 3 (2): 67–72. https://doi.org/10.1159/000071025
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk Patients
Lars Kjøller-Hansen; Jens J. Thiis; Rolf Steffensen; Peer Grande
Heart Drug (2003) 3 (2): 73–81. https://doi.org/10.1159/000071992
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Clinical Study

The Influence of Multiple Variables on the Prevalence of Aspirin Prescribing in Patients with Known Coronary Artery Disease
Erick Avelar; Scott E. Woods; Meg Doerzbacher; Sharyn Borckardt
Heart Drug (2003) 3 (2): 82–86. https://doi.org/10.1159/000071993
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Standardization of Core Laboratories

Intraoperative Stress Echocardiography
Raban V. Jeger; Miodrag Filipovic; Peter T. Buser; Manfred D. Seeberger
Heart Drug (2003) 3 (2): 87–96. https://doi.org/10.1159/000071994
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Review

Investigation and Treatment of Subclinical Coronary Atherosclerosis
J.R. Davies; P.L. Weissberg
Heart Drug (2003) 3 (2): 97–106. https://doi.org/10.1159/000071027
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Making Two Wrongs Right – Case of Using a Patient’s Diabetes insipidus to Treat HisHeart Failure: Experience with Vasopress in Antagonists from Animal Studies and Clinical Trials
Michael C. Fischi; Benjamin Trichon; Eric Velazquez; Michael Blazing; Christopher O’Conner
Heart Drug (2003) 3 (2): 107–112. https://doi.org/10.1159/000071029
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Lessons in Trial Statistics

Interim Analyses in Clinical Trials
Eva Skovlund
Heart Drug (2003) 3 (2): 113–116. https://doi.org/10.1159/000071995
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Further Section

Congress Calendar
Heart Drug (2003) 3 (2): 117–118. https://doi.org/10.1159/000072955
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Subject Index Vol. 5, 2005
Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients: A Double-Blind Randomized Study
Nicorandil – Review of Pharmacological Properties and Clinical Applications
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
  • Online ISSN 1424-0556
  • Print ISSN 1422-9528
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal